Showing results (51-60 of 116) with videos related to
Sort By:
Pageof 12
Neurology|August 29, 2001
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS studyW Huang, G E Alexander, L Chang, et al.Clinical Pharmacology and Therapeutics|September 1, 1995
Clinical pharmacokinetics of physostigmine in patients with Alzheimer's diseaseS Asthana, N H Greig, L Hegedus, et al.Psychiatry Research|December 1, 1991
Cerebral metabolic pattern in obsessive-compulsive disorder: altered intercorrelations between regional rates of glucose utilizationB Horwitz, S E Swedo, C L Grady, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1996
Differential response to the cholinergic agonist arecoline among different cognitive modalities in Alzheimer's diseaseK C Raffaele, S Asthana, A Berardi, et al.Annals of Internal Medicine|September 1, 1984
NIH Conference. Brain imaging: aging and dementiaN R Cutler, R Duara, H Creasey, et al.Hypertension (Dallas, Tex. : 1979)|September 1, 1992
Brain atrophy in hypertension. A volumetric magnetic resonance imaging studyJ A Salerno, D G Murphy, B Horwitz, et al.Journal of Cognitive Neuroscience|August 24, 2013
Functional Associations among Human Posterior Extrastriate Brain Regions during Object and Spatial VisionB Horwitz, C L Grady, J V Haxby, et al.The American Journal of Psychiatry|February 1, 1997
Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesisG E Alexander, M L Furey, C L Grady, et al.Brain and Language|January 1, 1994
Abnormal pattern of cerebral glucose metabolic rates involving language areas in young adults with Down syndromeN P Azari, B Horwitz, K D Pettigrew, et al.The American Journal of Psychiatry|December 10, 1999
High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS studyW Huang, G E Alexander, E M Daly, et al.Pageof 12